Nitro Nina

The story

Nina feels her familiar chest pressure while climbing stairs. She sits on the steps, places one nitroglycerin tablet under her tongue, and feels the expected warm flush and mild headache as the pain melts away.

Nina is a beloved community theater director known for her split-second timing, calling every light and sound cue with a stopwatch precision that never fails to impress her cast. That obsession with exact timing becomes a matter of life and safety after Nina is diagnosed with stable angina and prescribed sublingual nitroglycerin, a rapid-acting nitrate that dilates her veins, reducing the workload and oxygen demand on her heart while improving blood flow through her narrowed coronary arteries. Nina's chest pain, caused by myocardial ischemia whenever her heart's oxygen demand outpaces its supply, is meant to ease within minutes of a properly timed sublingual dose. But the same vasodilation that relieves her angina also drops her blood pressure and can cause headaches, and combining nitroglycerin with certain other medications can produce a catastrophic, synergistic collapse in blood pressure.

Nina carries her nitroglycerin tablets everywhere in their original dark glass bottle, exactly as instructed, and has used them successfully several times during rehearsals when the stress of directing brings on her familiar chest tightness. One afternoon during a particularly demanding tech rehearsal, Nina feels the telltale pressure begin building across her chest and immediately sits down, placing one tablet under her tongue exactly as trained. She notices the expected tingling sensation and a mild headache develop within a couple of minutes, both reassuring signs that the tablet remains potent and is working as intended, and she waits patiently, watching the clock on the wall the way she watches every cue during a live show.

Five minutes pass and Nina's chest pain has not improved at all; if anything, it feels slightly worse, and she now also notices a tight band radiating into her left jaw. Following her physician's protocol precisely, she takes a second sublingual tablet, again noting the familiar tingling and headache, but another five minutes brings no meaningful relief. Her assistant, alarmed by Nina's pale, sweaty appearance, checks her blood pressure and finds it has dropped to 88 over 54 while her heart rate has climbed to 104 beats per minute. Persistent, unrelieved chest pain despite two doses at the appropriate five-minute intervals is no longer a routine angina episode; it signals a possible evolving myocardial infarction requiring immediate emergency evaluation rather than a third home dose.

Nina's assistant calls 911 immediately rather than allowing Nina to drive herself or wait any longer, exactly per the established protocol that unrelieved pain after the first dose warrants emergency activation rather than continued home management. Paramedics keep Nina seated or reclined to minimize the fainting risk from her already low blood pressure, apply supplemental oxygen, and establish cardiac monitoring en route to the hospital. In the emergency department, the nurse confirms Nina has not taken any erectile dysfunction medications, since combining nitrates with phosphodiesterase-5 inhibitors causes dangerous synergistic hypotension, and continues frequent blood pressure and pain reassessments while cardiac enzymes and an electrocardiogram are obtained to rule out an evolving infarction.